期刊文献+

均匀设计联用星点设计优化白藜芦醇固体脂质纳米粒制备处方 被引量:12

Optimized formulation of resveratrol solid lipid nanoparticles by uniform design in combination with central composite design/response surface methodology
下载PDF
导出
摘要 目的:建立准确、快速的白藜芦醇固体脂质纳米粒制备处方的优化方法。方法:先采用均匀实验设计初步优化影响白藜芦醇固体脂质纳米粒的处方配比的五个影响因素,以包封率、载药量、平均粒径及多分散指数为指标,通过多元线性回归方程确定处方中影响指标的主要因素,再采用星点设计-效应面法进一步优化处方,以包封率、载药量及归一化值为指标,通过非线性数学模型描绘的效应面优选处方配比。结果:均匀设计和星点设计联用后得到的优化处方制备的样品平均粒径为167nm、多分散指数为0.176、包封率为56.77、载药量为2.59。结论:均匀设计联用星点设计用于白藜芦醇处方配比的优化是一种简便、高效和模型预测好的实验方法。 AIM: To establish a method of optimizing the formulation of resveratrol solid lipid nanoparticles (SLN) quickly and accurately by uniform design in combination with central composite design and response surface. METHODS : Firstly, uniform design was used to optimize the main factors from the five influence factors such as entrapment efficiency, drug loading, average diameter, and PDI ( Polydispersity Index). Then, on the ground of it, the main factors determined by unifrom design were optimized by central composite design with three evaluation parameters and response surfaces were nonlineated according to best-fit mathematic models, so optimized formulation was obtained. RESULTS: According to the optimal conditions, the entrapment efficiency, the drug loading, the average diameter and the PDI( Polydispersity Index) of the prepared Res-SLN were 56.77% ,2.59% , 167 nm and 0. 176, respectively. CONCLUSION : The design of combination of uniform design with central composite design is a feasible and convenient method to optimize the prescription of Res-SLN.
出处 《中成药》 CAS CSCD 北大核心 2007年第8期1139-1142,共4页 Chinese Traditional Patent Medicine
关键词 均匀设计 星点设计 白藜芦醇 固体脂质纳米粒 uniform design central composite design resveratrol solid lipid nanaoparticles
  • 相关文献

参考文献10

  • 1江文沁,沈金芳.白藜芦醇的药理活性及作用机制[J].药学进展,2003,27(3):159-162. 被引量:30
  • 2Elisabeth W,Tomislav S,Helmut E,et al.Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats[J].Mol Nutr Food Res,2005,49,482.
  • 3Elizabeth W,Veronika S.Review Metabolism and bioavailability of trans-resveratrol[J].Mol Nutr Food Res,2005,49,472.
  • 4Pinto JF.Preparation of oral-administrated solid lipid nanoparticles using pellets as carrier[J].Pharm,1999,54(7):506.
  • 5Yang S,Zhu J,Lu Y,et al.Body distribution of camptothechin solid lipid nanoparticles after oral administration[J].Pharm Res,1999,16(5):751.
  • 6Wang YM,Sato H,Adachi I,et al.Optimization of the formulation design of chitosan microspheres containing cisplatin[J].J Pharm Sci,1996,85 (11):1204.
  • 7王鹏,王玉珠,沈建民.均匀设计及其在药学中的应用[J].沈阳药学院学报,1989,6(4):297-305. 被引量:74
  • 8Branchu S,Fo rbes RT,York P,et al.A central composite design to investigate the thermal stabilization of lysozyme[J].Pharm Res,1999,16(5):702.
  • 9Schubert M A,Muller G C C.Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters[J].Eur J Pharm Biopharm,2003,55:125.
  • 10吴伟,崔光华,陆彬.实验设计中多指标的优化:星点设计和总评“归一值”的应用[J].中国药学杂志,2000,35(8):530-533. 被引量:310

二级参考文献29

  • 1王鹏,王玉珠,沈建民.均匀设计及其在药学中的应用[J].沈阳药学院学报,1989,6(4):297-305. 被引量:74
  • 2王剑红,陆彬,胥佩菱,包定元,张自然.肺靶向米托蒽醌明胶微球的研究[J].药学学报,1995,30(7):549-555. 被引量:25
  • 3Ragione F D, Cucciolla V, Borriello A, et al. Resveratrol arrests the cell division cycle at S/G2 phase transition[J].Biochem Biophys Res Commun, 1998, 250:53-58.
  • 4Tsan M F, White J E, Maheshwari J G, et al. Antileukemia effect of resveratrol[J]. Leuk Lymphoma, 2002,43(5): 983-987.
  • 5El-Mowafy A M, Abou-Zeid L A, Edafiogho I. Recognition of resveratrol by the human estrogen receptor-alpha: a molecular modeling approach to understand its biological actions[J]. Med Princ Pract, 2002, 11(2): 86-92.
  • 6Mizutani K, Ikeda K, Kawai Y, et aL Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats[J]. J Nutr Sci Vitaminol(Tokyo), 2000, 46: 78-83.
  • 7Hsieh T C, Wu J M. Differential effects on growth, cell cycle arrest, and induction of apoptc~is by resveratrol in human prostate cancer cell lines[J].Exp Cell Res, 1999,249: 109-115.
  • 8Burns J, Yokota T, Ashihara H, et al. Plant foods and herbal sources of resveratrol[J]. J Agric Food Chem, 2002,50(11):3337-3340.
  • 9Shin N H, Ryu S Y, Lee H, et al.Inhibitory effects of hydroxystilbenes on cyclooxygenase from sheep seminal vesicles[J]. Planta Med, 1998, 64:283-284.
  • 10Bhat K P, Pezzuto J M. Related cancer chemopreventive activity of resveratrol[J]. Ann N Y Acad Sci, 2002, 957:210-229.

共引文献409

同被引文献129

引证文献12

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部